Delivery Order SPE2DB22D2211-SPE2DB25FSANY
- Not listed
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,076,721 units of the biologic medication CIMZIA (certolizumab pegol) 2x200 mg/mL syringe kits, with a ceiling value of $6,892.75 and a period of performance through April 30, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,004.34 contract is for the delivery of 4,568,232,858 units of the pharmaceutical product CIMZIA 2X200 MG/ML SYRINGE KITS. The contract has a period of performance through May 14, 2025 and does not have a set-aside designation, indicating open competition. This delivery order is likely part of a...
- This is a Delivery Order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Medical Supply Chain. The order is for 4,566,584,213 units of CIMZIA 2X200 MG/ML Syringe Kits, with a Firm Fixed Price ceiling value of $43,158.38 and a completion date of December 3, 2024. This appears to be part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026,...
- This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $40,114.45, is for the delivery of 4,568,202 units of the pharmaceutical product CIMZIA 2X200 MG/ML SYRINGE KITS. The contract has a performance period through May 12, 2025 and does not include a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,039,841 units of the medication CIMZIA 2X200 MG/ML SYRINGE KITS, with a firm fixed price ceiling value of $4,831.52. The contract has an ultimate completion date of April 28, 2025 and was awarded on April 25, 2025. This delivery order is part of a larger Indefinite...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,528,590 units of the drug CIMZIA (certolizumab pegol) 2X200 mg/mL syringe kits, with a ceiling value of $7,061.06 and a completion date of June 13, 2025. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00...
- This is a $7,149.86 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CIMZIA 2X200 MG/ML syringe kits, with a performance period extending through June 12, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,568,123,197 units of the medication CIMZIA 2X200 MG/ML SYRINGE KITS, with a ceiling value of $27,118.73 and a period of performance through May 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,722,360 units of the medication CIMZIA 2X200 MG/ML SYRINGE KITS. The contract has a firm fixed price of $7,361.36 and a completion date of July 8, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,830.41, is for the delivery of 4,568,119,270 units of the medication CIMZIA 2X200 MG/ML SYRINGE KITS. The contract is a firm fixed-price, non-set-aside award with a completion date of May 5, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSANYDelivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,748,554 units of the medication CIMZIA 2X200 MG/ML SYRINGE KITS, with a ceiling value of $7,061.06 and a period of performance through July 10, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.1k | 7/9/25 |